We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Offers diagnostic imaging products, including FCR” digital x-ray imaging and diagnostic systems, “Synapse” medical-us... read more Featured Products: More products

Download Mobile App

Fujifilm’s Antiviral Becomes First Approved Drug to Treat Coronavirus in China

By HospiMedica International staff writers
Posted on 23 Mar 2020
Print article
Image: Favilavir (Photo courtesy of Fujifilm Toyama Chemical)
Image: Favilavir (Photo courtesy of Fujifilm Toyama Chemical)
Fujifilm Toyama Chemical’s (Tokyo, Japan) flu drug Favilavir, which is currently being promoted with the label, Avigan, has become the first-ever antiviral medicine to be approved for use as a treatment for COVID-19 in China. The National Medical Products Administration of China has approved Favilavir for treating the now-declared pandemic illness after it appeared to be effective in coronavirus patients during clinical studies.

Favilavir, which has proven to be an effective antiviral drug for fighting RNA infections by inhibiting the RNA-dependent RNA polymerase, or RdRp, is mainly used for treating influenza in Japan and China. According to medical authorities in China, Favipiravir had delivered encouraging outcomes in clinical trials of 340 coronavirus-infected patients in Wuhan and Shenzhen. The Ministry of Science and Technology of China has stated that Favilavir was shown to prevent COVID-19 from spreading and further damaging the health of patients in clinical studies. According to reports, the patients in Shenzhen who were administered Favilavir turned negative for the coronavirus after a median of four days after becoming positive, as compared to a median of 11 days for patients who were not treated with the drug. Additionally, X-rays showed improvements in the lung condition of 91% of the patients who were administered Favipiravir, as compared to 62% of patients who were not treated with the drug.

Despite its potential, the US Food and Drug Administration (FDA) has not yet regarded Favilavir as an effective treatment medicine for coronavirus. Nevertheless, doctors in Japan are said to be conducting clinical studies of Favilavir on coronavirus patients having mild to moderate symptoms in the hope of preventing the virus from multiplying in the patients.

Related Links:
Fujifilm Toyama Chemical

BMP Whole Blood Analyzer: GEM Premier ChemSTAT
Gold Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Benchtop Coagulation Analyzer
3 & 5-Part All-In-One Auto Hematology Analyzer

Print article



view channel
Image: AI transforms smartwatch ECG signals into a diagnostic tool for heart failure (Photo courtesy of Pexels)

AI-Based Smartwatch Accurately Detects Heart Failure Using ECG Signals

People with a weak heart pump might not have symptoms, but this common form of heart disease affects about 2% of the population and 9% of people over 60. When the heart cannot pump enough oxygen-rich blood,... Read more

Critical Care

view channel
Image: PATHFAST is a compact immunoanalyzer with superior assay performance (Photo courtesy of PHC Europe)

Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC

A compact immunoanalyzer with superior assay performance combines the accuracy of a full-scale lab analyzer with the flexibility of a mobile solution, making it an ideal analysis system for laboratories,... Read more

Surgical Techniques

view channel
Image: Bioelectric medicine could stem excessive blood loss (Photo courtesy of Pexels)

Wearable Neurostimulation Solution Could Stem Excessive Blood Loss in the OR

A wearable neurostimulation solution focused on lessening excessive blood loss could save precious time for surgical teams in the operating room. A collaboration between Spark Biomedical, Inc.... Read more

Patient Care

view channel
Image: The digital stretcher scales are designed specifically for emergent situations in hospitals and emergency rooms (Photo courtesy of DETECTO)

Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER

For emergency arrivals into a hospital, time is of the essence for gathering patient weights. Now, digital stretcher scales specifically designed for emergent situations in hospitals and emergency rooms... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more


view channel
Image: The global visualization instruments for MIS market is estimated to surpass USD 21 billion by 2031 (Photo courtesy of Pexels)

Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures

The last few years have witnessed an increase in patient preference for medical surgeries that involve fewer incisions. As a result, the demand for visualization instruments, which aid in achieving improved... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.